A Study of ASP1002 in Adults for Treatment of Solid Tumors

ClinicalTrials.gov ID: NCT05719558

Public ClinicalTrials.gov record NCT05719558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study of ASP1002 in Participants With Metastatic or Locally Advanced Solid Tumors

Study identification

NCT ID: NCT05719558
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Enrollment: 210 participants

Conditions and interventions

Conditions

Advanced Solid Tumors

Interventions

ASP1002 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 12, 2023
Primary completion: Apr 29, 2028
Completion: May 30, 2028
Last update posted: Mar 17, 2026

2023 – 2028

United States locations

U.S. sites: 15
U.S. states: 13
U.S. cities: 14

Facility	City	State	ZIP	Site status
Yale University Cancer Center	New Haven	Connecticut	06520	Recruiting
Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut	Plainville	Connecticut	06062	Recruiting
University of Florida	Gainesville	Florida	32610	Recruiting
University of Iowa Hospitals	Iowa City	Iowa	52242	Recruiting
Norton Cancer Institute	Louisville	Kentucky	40202	Recruiting
Henry Ford Hospital	Detroit	Michigan	48202	Recruiting
HealthPartners Cancer Research Center	Saint Paul	Minnesota	55101	Recruiting
Icahn School of Medicine at Mount Sinai	New York	New York	10029	Recruiting
University Hospitals of Cleveland	Cleveland	Ohio	44106	Recruiting
Prisma Health-Upstate Cancer Institute	Greenville	South Carolina	29605	Completed
SCRI Oncology Partners	Nashville	Tennessee	37203	Completed
University of Texas Southwestern	Dallas	Texas	75235	Completed
Mary Crowley Cancer Research Center	Dallas	Texas	75251	Recruiting
NEXT Oncology Virginia	Fairfax	Virginia	22031	Recruiting
Swedish Cancer Institute	Edmonds	Washington	21632	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05719558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 17, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05719558 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →